Skip to content

MESO

Mesoblast Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$15.13
+1.75%
Ask drillr

Margins

Gross margin
80.0%
EBITDA margin
-37.4%
EBIT margin
-42.8%
Net margin
-47.8%
FCF margin
-35.2%
-10.1%
Return on equity
-7.4%
Return on assets
-7.4%
Return on invested capital
0.16x
Asset turnover
-$41.3M
Cash from operations
$0.79
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026